Celltrion Pharm Inc.
068760 | KO
Overview
Corporate Details
- ISIN(s):
- KR7068760008
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 청원구 오창읍 2산단로 82셀트리온제약, 청주시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-29 00:00 |
Governance Information
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 8.9 KB | ||
| 2025-08-14 00:00 |
Regulatory Filings
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
|
Korean | 11.1 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 2.6 MB | ||
| 2025-06-23 00:00 |
Major Shareholding Notification
[기재정정]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
|
Korean | 135.3 KB | ||
| 2025-05-30 00:00 |
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
|
Korean | 100.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.4 MB | ||
| 2025-05-07 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.8 KB | ||
| 2025-04-10 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.9 KB | ||
| 2025-04-10 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 252.0 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.9 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB |
Automate Your Workflow. Get a real-time feed of all Celltrion Pharm Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Celltrion Pharm Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Celltrion Pharm Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing oral precision therapies for inflammatory and fibrotic intestinal diseases like colitis.
United States of America
PALI
United States of America
PALI
Clinical-stage biopharma developing topical therapies for rare genetic skin diseases.
United States of America
PVLA
United States of America
PVLA
Develops biosimilars and provides CHO-based CDMO services for the global biopharma industry.
South Korea
222110
South Korea
222110
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway
PCIB
Norway
PCIB
Biopharma with an approved gel for molluscum, advancing a nitric oxide-based pipeline.
United States of America
PTHS
United States of America
PTHS
Develops radiopharmaceuticals for diagnosing and treating oncology and adrenal disorders.
Germany
PTP
Germany
PTP
Develops blood tests for early diagnosis of neurodegenerative diseases like Alzheimer's.
South Korea
304840
South Korea
304840
Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.
Japan
4587
Japan
4587
Develops clinically proven self-care products for women's intimate health.
Sweden
PMED
Sweden
PMED